V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220007401 | 220002910 | null | 0 | null | 2016-04-30 | 2016-05-01 | Idarubicin+Tretinoin Spanish Crse2 | N | N | 220032328 | IDARUBICIN + TRETINOIN |
| 220007402 | 220002911 | 1.65 | 77.5 | Curative (C) | 2013-04-29 | 2013-05-01 | AML 18 TRIAL | Y | N | 220032330 | AML18 TRIAL |
| 220007403 | 220011644 | 1.5 | 85 | Palliative (P) | 2015-10-03 | 2015-10-03 | Dasatinib | 02 | N | 220032331 | DASATINIB |
| 220007404 | 220002912 | 1.7 | 126 | Curative (C) | 2015-11-27 | 2015-11-27 | AML 18 Pilot Trial | N | N | 220032333 | PILOT TRIAL |
| 220007405 | 220002913 | 1.74 | null | Palliative (P) | 2016-02-02 | 2016-03-21 | Cisplatin+Gemcitabine (gallbladder) | 2 | N | 220032336 | CISPLATIN + GEMCITABINE |
| 220007406 | 220002914 | 1.56 | 83.5 | Palliative (P) | 2015-02-19 | 2015-02-25 | GemCarbo Days 1+8 | 2 | N | 220032338 | GEMCARBO |
| 220007407 | 220002915 | 1.74 | 88 | Curative (C) | 2017-08-20 | 2017-08-24 | AML18 PILOT TRIAL | 1 | N | 220032339 | PILOT TRIAL |
| 220007408 | 220002916 | null | 90 | Palliative (P) | 2016-03-22 | 2016-03-27 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 220032342 | CARBOPLATIN + PACLITAXEL |
| 220007409 | 220002916 | 1.64 | 57.6 | Palliative (P) | 2014-11-17 | 2014-11-22 | CISPLATIN + GEMCITABINE | 02 | Y | 220032342 | CISPLATIN + GEMCITABINE |
| 220007410 | 220002916 | 1.71 | 85.3 | null | 2016-08-26 | 2016-08-26 | IDARUBICIN + TRETINOIN | N | N | 220032342 | IDARUBICIN + TRETINOIN |
| 220007411 | 220002916 | 1.52 | null | Curative (C) | 2017-03-30 | 2017-03-30 | AML 18 TRIAL | Y | N | 220032342 | AML18 TRIAL |
| 220007412 | 220002917 | 1.51 | 63.8 | Palliative (P) | 2016-10-23 | 2016-11-10 | GEMCARBO | N | N | 220032349 | GEMCARBO |
| 220007413 | 220002918 | 1.6 | 64.1 | Disease modification (D) | 2017-02-25 | 2017-02-25 | AML18 PILOT TRIAL | Y | N | 220032350 | PILOT TRIAL |
| 220007414 | 220002919 | 1.65 | 84 | Curative (C) | null | 2014-03-08 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 220032351 | CARBOPLATIN + PACLITAXEL |
| 220007415 | 220002920 | 1.76 | 108 | Curative (C) | 2014-07-31 | 2014-09-04 | AML18 PILOT TRIAL | Y | N | 220032353 | PILOT TRIAL |
| 220007416 | 220002921 | 1.55 | 96.9 | Curative (C) | 2014-07-27 | 2014-07-27 | IDARUBICIN + TRETINOIN | Y | null | 220032358 | IDARUBICIN + TRETINOIN |
| 220007417 | 220002922 | 1.49 | 67.8 | Curative (C) | 2014-03-13 | 2014-03-13 | IDARUBICIN + TRETINOIN | 2 | Y | 220032359 | IDARUBICIN + TRETINOIN |
| 220007418 | 220002923 | null | 51.1 | Palliative (P) | 2014-04-28 | 2014-05-07 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220032362 | CARBOPLATIN + PACLITAXEL |
| 220007419 | 220002923 | null | 94.9 | Curative (C) | 2017-10-17 | 2017-11-25 | CARBOPLATIN + PACLITAXEL | null | N | 220032362 | CARBOPLATIN + PACLITAXEL |
| 220007422 | 220002926 | 1.83 | 0 | Curative (C) | 2013-03-14 | 2013-03-14 | AML 18 TRIAL | Y | N | 220032371 | AML18 TRIAL |
| 220007423 | 220002927 | 1.88 | null | Curative (C) | 2014-02-03 | 2014-03-11 | Idarubicin+Tretinoin Spanish Crse4 | 02 | N | 220032372 | IDARUBICIN + TRETINOIN |
| 220007424 | 220002928 | 1.63 | 57.4 | Curative (C) | null | 2013-10-16 | AML16 DA 3+10 | Y | N | 220032378 | AML16 TRIAL |
| 220007425 | 220002928 | 1.84 | 88.7 | null | 2015-05-09 | 2015-05-30 | AML16 DA 3+10 | N | N | 220032378 | AML16 TRIAL |
| 220007426 | 220002928 | 1.88 | 84.8 | Curative (C) | 2017-02-19 | 2017-02-19 | AML 18 TRIAL | Y | null | 220032378 | AML18 TRIAL |
| 220007427 | 220002928 | 1.65 | 48 | Palliative (P) | 2014-11-10 | 2014-12-24 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 220032378 | CISPLATIN + GEMCITABINE |
| 220007428 | 220020419 | 1.8 | 99.8 | Curative (C) | 2013-04-30 | 2013-05-01 | AML 18 TRIAL | Y | N | 220032385 | AML18 TRIAL |
| 220007429 | 220002929 | null | 54.2 | null | 2015-01-03 | 2015-01-04 | AML 18 TRIAL | Y | N | 220032386 | AML18 TRIAL |
| 220007430 | 220002930 | 1.75 | 100 | Palliative (P) | 2016-01-24 | 2016-01-29 | CISPLATIN + GEMCITABINE | Y | N | 220032387 | CISPLATIN + GEMCITABINE |
| 220007431 | 220002931 | 1.72 | null | Curative (C) | 2014-01-21 | 2014-01-21 | IDARUBICIN + TRETINOIN | N | N | 220032391 | IDARUBICIN + TRETINOIN |
| 220007432 | 220002931 | 1.53 | 48.1 | Palliative (P) | 2013-08-26 | 2013-09-17 | GemCarbo Days 1+8 | N | N | 220032391 | GEMCARBO |
| 220007433 | 220002932 | 1.69 | null | Curative (C) | null | 2016-01-22 | AML 18 TRIAL | 01 | N | 220032395 | AML18 TRIAL |
| 220007434 | 220002932 | 1.73 | 72 | Disease modification (D) | 2016-09-13 | 2018-07-25 | Dasatinib | N | N | 220032395 | DASATINIB |
| 220007435 | 220002932 | 1.78 | null | Curative (C) | 2013-08-20 | 2013-08-23 | AML 18 TRIAL | Y | N | 220032395 | AML18 TRIAL |
| 220007436 | 220002932 | 1.77 | 76.9 | Disease modification (D) | 2014-03-01 | 2014-03-01 | AML18 PILOT TRIAL | null | N | 220032395 | PILOT TRIAL |
| 220007437 | 220002932 | 1.6 | null | Palliative (P) | 2014-06-14 | 2014-07-29 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 220032395 | CISPLATIN + GEMCITABINE |
| 220007438 | 220021283 | null | 86.5 | null | 2017-07-31 | 2017-08-14 | GEMCARBO | N | N | 220032407 | GEMCARBO |
| 220007439 | 220021283 | 1.84 | null | Palliative (P) | 2014-05-15 | 2014-06-17 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220032407 | CARBOPLATIN + PACLITAXEL |
| 220007440 | 220021283 | 1.62 | 64.8 | Palliative (P) | 2014-12-20 | 2014-12-26 | CISPLATIN + GEMCITABINE | N | N | 220032407 | CISPLATIN + GEMCITABINE |
| 220007441 | 220021283 | 1.57 | 64.9 | null | 2014-05-16 | 2014-05-23 | CARBOPLATIN + GEMCITABINE | N | Y | 220032407 | GEMCARBO |
| 220007442 | 220002933 | null | 86.5 | null | 2016-11-26 | 2016-11-26 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 220032412 | CISPLATIN + GEMCITABINE |
| 220007443 | 220002933 | 1.61 | null | null | 2016-07-16 | 2016-07-24 | GEMCARBO | N | N | 220032412 | GEMCARBO |
| 220007444 | 220002933 | null | 128 | Curative (C) | 2013-09-28 | 2013-09-28 | AML 18 TRIAL | 01 | Y | 220032412 | AML18 TRIAL |
| 220007445 | 220002933 | 0 | 63 | Curative (C) | null | 2016-12-24 | AML16 DA 3+8 | null | N | 220032412 | AML16 TRIAL |
| 220007446 | 220020421 | 1.78 | 85.3 | Palliative (P) | 2017-05-20 | 2017-05-21 | Cisplatin+Gemcitabine (gallbladder) | 2 | Y | 220032423 | CISPLATIN + GEMCITABINE |
| 220007447 | 220020421 | 1.71 | 75.6 | Curative (C) | 2015-07-30 | 2015-07-30 | IDARUBICIN + TRETINOIN | N | N | 220032423 | IDARUBICIN + TRETINOIN |
| 220007448 | 220020421 | 1.73 | 93.2 | Curative (C) | 2016-05-23 | 2016-05-23 | IDARUBICIN + TRETINOIN | N | N | 220032423 | IDARUBICIN + TRETINOIN |
| 220007450 | 220011651 | 1.73 | 138.8 | Curative (C) | 2017-08-19 | 2017-08-24 | AML16 DA 3+10 | null | N | 220032444 | AML16 TRIAL |
| 220007451 | 220002935 | null | 105 | Palliative (P) | 2013-07-20 | 2013-08-08 | GemCarbo Days 1+8 | 02 | null | 220032445 | GEMCARBO |
| 220007452 | 220011652 | 1.76 | 100 | Curative (C) | 2015-07-30 | 2015-07-31 | AML 18 TRIAL | Y | N | 220032447 | AML18 TRIAL |
| 220007453 | 220011652 | 1.67 | 89.6 | Curative (C) | 2014-10-23 | 2014-11-18 | CARBOPLATIN + PACLITAXEL | N | N | 220032447 | CARBOPLATIN + PACLITAXEL |